-
10:20 AM EST 2/8/2012
Agencies pledge science-based Arctic decisionsAgencies pledge science-based Arctic decisions
-
7:15 PM EST 2/7/2012
200 years on, it's still a Dickensian world
Charles Dickens' great, great grandson calls the writer a "great social reformer" -- and his themes still resonate
-
2:52 AM EST 1/3/2009
ConocoPhillips Loses $7 Billion on LUKOIL Stake in 2008The Company: ConocoPhillips, an integrated energy company with interests around the world. The Filing: FORM 10-Q filed with the SEC on October 29, 2008. The Finding: The 2006 acquisition of a 20 percent stake in LUKOIL by ConocoPhillips, initially applauded by energy analysts because it increase...
-
1:07 PM EDT 5/6/2008
Big Hurdles Remain in ConocoPhillips-Tyson Biodiesel VentureTyson Foods and ConocoPhillips continue to move forward with plans to profitably convert animal fats into renewable diesel fuel, with a rollout planned for Spring 2009. Although demand for renewable fuels is high, it is doubtful the diesel will be shipped and distributed through existing pipelines f...
-
7:51 AM EDT 6/17/2011
Inside Takeda's Drug-Drought TrapJapanese drugmaker Takeda has no shortage of things to worry about, including expiring patents, a cancer link to its leading diabetes med, and a meager pipeline.
-
12:02 PM EDT 4/25/2011
Skecher's Shape-Ups Face a Flabby FutureSkechers thinks its profits will rebound once it "clears" inventory of lower-margin "Shape-up" toning shoes, but its real problems are new rivals and a flood of cheaper substitute shoes.
-
2:19 PM EDT 3/18/2011
Future Demand for Cameco's Uranium Fuel Still Red-Hot, Despite Japan's MeltdownCameco closed lower again Thursday on fears long-term demand for uranium will slow in the aftermath of Japanese reactor problems. Even a partial meltdown at the shattered facility is unlikely to halt insatiable worldwide hunger for more sources of electricity - including nuclear energy.
-
1:08 PM EDT 3/16/2011
InterMune's New Lung-Disease Drug Doesn't Deserve Its HypeAnalysts think InterMune's lung-disease drug Esbriet can expect sales in excess of $1 billion annually. But it's only sold in the EU, and there's little proof the drug actually works.
-
12:46 PM EDT 3/15/2011
GE's Getting Hammered, but It Won't Take the Fall for Japan's Potential ChernobylShares in General Electric tumbled for a second day as fears mount of a meltdown at the Fukushima Daiichi nuclear power plant, located about 150 miles northeast of Tokyo. Given 24/7 news coverage of the Japanese earthquake and subsequent disaster, selling pressure more likely mirrors nightmarish headlines of another "Chernobly" disaster in the making, rather than actual financial risk exposure to the U.S.-based conglomerate.
-
3:11 PM EST 3/3/2011
Can Italian Oil Giant Eni SpA Prosper in a Qaddafi-Free Libya? SurePolitical unrest in Qaddafi's Libya would seem to give Italian energy giant Eni SpA a lot to worry about. But Eni's geopolitically balanced portfolio of upstream production should limit the fallout.
- Narrow search
- Date
- Today (2)
- This Week (4)
- This Month (15)
- This Year (184)
- Media Type
- Story (1023)
- Blog (88)
- Photo Essay (42)
- Video (28)
- Type
- Markets & Investing (415)
- HOME (199)
- U.S. (176)
- World (160)
- Entertainment (109)
- See all
- Shows
- Markets & Investing (415)
- World (82)
- U.S. (71)
- Entertainment (65)
- PaidContent (40)
- See all
